Jonathan Maher

5.4k total citations
53 papers, 4.2k citations indexed

About

Jonathan Maher is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jonathan Maher has authored 53 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Oncology and 15 papers in Pharmacology. Recurrent topics in Jonathan Maher's work include Drug Transport and Resistance Mechanisms (22 papers), Genomics, phytochemicals, and oxidative stress (19 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). Jonathan Maher is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Genomics, phytochemicals, and oxidative stress (19 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). Jonathan Maher collaborates with scholars based in United States, Japan and Czechia. Jonathan Maher's co-authors include Curtis D. Klaassen, Masayuki Yamamoto, Angela L. Slitt, Xingguo Cheng, Takafumi Suzuki, Matthew Z. Dieter, Nathan J. Cherrington, Hozumi Motohashi, Yuji Tanaka and José E. Manautou and has published in prestigious journals such as Molecular and Cellular Biology, Hepatology and Cancer Research.

In The Last Decade

Jonathan Maher

53 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Maher United States 35 2.3k 1.3k 711 501 479 53 4.2k
Naohiko Anzai Japan 46 2.9k 1.2× 2.1k 1.7× 553 0.8× 838 1.7× 343 0.7× 213 6.8k
José E. Manautou United States 39 2.1k 0.9× 1.3k 1.0× 1.4k 2.0× 465 0.9× 921 1.9× 112 4.9k
Masuhiro Nishimura Japan 28 1.0k 0.5× 996 0.8× 879 1.2× 350 0.7× 244 0.5× 92 3.4k
Masahiro Tohkin Japan 29 1.4k 0.6× 1.6k 1.2× 1.1k 1.5× 377 0.8× 666 1.4× 120 4.6k
Julie B. Stimmel United States 22 2.3k 1.0× 1.9k 1.5× 847 1.2× 208 0.4× 609 1.3× 28 4.7k
Shinsaku Naito Japan 27 966 0.4× 1.0k 0.8× 966 1.4× 332 0.7× 215 0.4× 82 3.1k
Seok Ho South Korea 34 2.0k 0.9× 2.7k 2.1× 515 0.7× 1.2k 2.4× 329 0.7× 79 6.1k
Junko Sugatani Japan 34 1.2k 0.5× 532 0.4× 692 1.0× 420 0.8× 326 0.7× 100 3.4k
Randy K. Bledsoe United States 19 2.5k 1.1× 2.0k 1.6× 893 1.3× 215 0.4× 582 1.2× 23 5.3k
Jean‐Marc Pascussi France 40 1.6k 0.7× 1.8k 1.4× 2.8k 3.9× 531 1.1× 420 0.9× 92 5.9k

Countries citing papers authored by Jonathan Maher

Since Specialization
Citations

This map shows the geographic impact of Jonathan Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Maher more than expected).

Fields of papers citing papers by Jonathan Maher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Maher. The network helps show where Jonathan Maher may publish in the future.

Co-authorship network of co-authors of Jonathan Maher

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Maher. A scholar is included among the top collaborators of Jonathan Maher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Maher. Jonathan Maher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fullerton, Aaron, Jochen Brumm, Tomomi Kiyota, et al.. (2020). In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk. Archives of Toxicology. 94(9). 3185–3200. 6 indexed citations
2.
Katavolos, Paula, Gary Cain, Cindy Farman, et al.. (2020). Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs. Toxicologic Pathology. 48(3). 465–480. 8 indexed citations
3.
Canet, Mark J., Matthew D. Merrell, Bryan Harder, et al.. (2014). Identification of a Functional Antioxidant Response Element within the Eighth Intron of the Human ABCC3 Gene. Drug Metabolism and Disposition. 43(1). 93–99. 19 indexed citations
4.
Taguchi, Keiko, Jonathan Maher, Takafumi Suzuki, et al.. (2010). Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1. Molecular and Cellular Biology. 30(12). 3016–3026. 196 indexed citations
5.
Suzuki, Takafumi, Jonathan Maher, & Masayuki Yamamoto. (2010). Select Heterozygous Keap1 Mutations Have a Dominant-Negative Effect on Wild-Type Keap1 In Vivo. Cancer Research. 71(5). 1700–1709. 47 indexed citations
6.
Satoh, Hironori, Takashi Moriguchi, Keiko Taguchi, et al.. (2010). Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis. 31(10). 1833–1843. 165 indexed citations
7.
Okada, Kosuke, Junichi Shoda, Keiko Taguchi, et al.. (2009). Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochemical and Biophysical Research Communications. 389(3). 431–436. 73 indexed citations
8.
Maher, Jonathan, Lauren M. Aleksunes, Matthew Z. Dieter, et al.. (2008). Nrf2- and PPARα-Mediated Regulation of Hepatic Mrp Transporters after Exposure to Perfluorooctanoic Acid and Perfluorodecanoic Acid. Toxicological Sciences. 106(2). 319–328. 93 indexed citations
9.
Okada, Kosuke, Junichi Shoda, Keiko Taguchi, et al.. (2008). Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(4). G735–G747. 123 indexed citations
10.
Maher, Jonathan, Matthew Z. Dieter, Lauren M. Aleksunes, et al.. (2007). Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor-E2–related factor-2 transcriptional pathway. Hepatology. 46(5). 1597–1610. 263 indexed citations
11.
Tanaka, Yuji, Chuan Chen, Jonathan Maher, & Curtis D. Klaassen. (2007). Ischemia-Reperfusion of Rat Livers Decreases Liver and Increases Kidney Multidrug Resistance–Associated Protein 2 (Mrp2). Toxicological Sciences. 101(1). 171–178. 30 indexed citations
12.
Iida, Katsuyuki, Ken Itoh, Jonathan Maher, et al.. (2007). Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis. Carcinogenesis. 28(11). 2398–2403. 68 indexed citations
13.
Fisher, Craig D., Lisa M. Augustine, Jonathan Maher, et al.. (2007). Induction of Drug-Metabolizing Enzymes by Garlic and Allyl Sulfide Compounds via Activation of Constitutive Androstane Receptor and Nuclear Factor E2-Related Factor 2. Drug Metabolism and Disposition. 35(6). 995–1000. 108 indexed citations
14.
Slitt, Angela L., Katryn Allen, Lauren M. Aleksunes, et al.. (2006). Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(3). 637–647. 63 indexed citations
15.
Moffit, Jeffrey S., Lauren M. Aleksunes, Jonathan Maher, et al.. (2006). Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α. Journal of Pharmacology and Experimental Therapeutics. 317(2). 537–545. 56 indexed citations
16.
Tanaka, Yuji, Chuan Chen, Jonathan Maher, & Curtis D. Klaassen. (2006). Kupffer Cell-Mediated Downregulation of Hepatic Transporter Expression in Rat Hepatic Ischemia-Reperfusion. Transplantation. 82(2). 258–266. 38 indexed citations
17.
Maher, Jonathan, Xingguo Cheng, Yuji Tanaka, George L. Scheffer, & Curtis D. Klaassen. (2006). Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. Biochemical Pharmacology. 71(10). 1470–1478. 36 indexed citations
18.
Aleksunes, Lauren M., Angela L. Slitt, Jonathan Maher, et al.. (2006). Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis. Cell Stress and Chaperones. 11(4). 356–356. 50 indexed citations
19.
Cheng, Xingguo, Jonathan Maher, Chuan Chen, & Curtis D. Klaassen. (2005). TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS). Drug Metabolism and Disposition. 33(7). 1062–1073. 137 indexed citations
20.
Slitt, Angela L., Nathan J. Cherrington, Jonathan Maher, & Curtis D. Klaassen. (2003). INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES. Drug Metabolism and Disposition. 31(9). 1176–1186. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026